ALICE POWELL: Open Payments
NPI 1386694560 · BAKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 21 payments from 12 companies in 2025. Trend: 2023 $677 · 2024 $581 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Novo Nordisk Inc | 3 | $49 |
| Lilly USA, LLC | 3 | $46 |
| ACADIA Pharmaceuticals Inc | 2 | $46 |
| PFIZER INC. | 2 | $44 |
| SANOFI PASTEUR INC. | 2 | $36 |
| Abbott Laboratories | 1 | $32 |
| Dexcom, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: KEVEYIS, MOUNJARO, DAYBUE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FREESTYLE LIBRE 3, PREVNAR 20, Dexcom G6 Transmitter, PAXLOVID.
Industry payments across LA — which companies pay providers there.
